Global Light Therapy Device Market - 2021-2028

Global Light Therapy Device Market - 2021-2028

Market Overview

The global light therapy device market size was valued at US$ XX million in 2020 and is estimated to reach US$ XX million by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Light therapy, also known as phototherapy, is a medical treatment involving using an artificial light source. The therapy is primarily used to treat the seasonal major depressive disorder (MDD) (formerly known as a seasonal affective disorder, or SAD).

Market Dynamics

The factors driving the global light therapy device market are technological advancements and the increasing incidence of skin diseases.

The technological advancements are expected to drive the global light therapy devices market in the forecast period

In the modern era of phototherapy, there have been a number of developments that brought new and better methods of treating skin diseases such as vitiligo and psoriasis, as well as numerous technological advances that have improved the safety and effectiveness of those new therapies. Light therapy affects brain chemicals associated with mood and sleep, alleviating SAD symptoms. Other types of sleep disorders, depression and other conditions may benefit from using a light therapy box. Light therapy is also known as phototherapy.

Phototherapy is a treatment that involves repeatedly exposing the skin to ultraviolet light to treat inflammatory skin conditions such as psoriasis. Recent research has identified specific immunologic effects of phototherapy that may contribute to its efficacy. Furthermore, recent advances in developing safe and effective targeted phototherapy modalities for difficult-to-treat areas such as scalp psoriasis have been made. Targeted phototherapy with the excimer laser can provide more aggressive, effective treatment and long-term psoriasis remission. Phototherapy is now used successfully with biological agents to treat recalcitrant psoriasis. As a result, despite being one of the oldest therapeutic modalities for psoriasis, phototherapy remains a mainstay treatment with promising prospects.

Hence, the increasing research and development about light therapy are expected to drive market growth.

The limitations associated with light therapy device is expected to hamper the market growth

Light therapy that only uses visible light is generally thought to be safe. Nonetheless, the use of phototherapy for people with drug-resistant non-seasonal depression can result in mania, a hyperactive state. Light therapy should be reduced or discontinued in these rare cases, and the condition should be adequately treated.

Any treatment that exposes the patient to UV radiation does not come without risks. To that end, some potential risks of light therapy include premature skin aging and an increased risk of developing skin cancer later in life. Light-induced eye strain and temporary headaches are also frequently reported, though these symptoms do not appear to indicate any permanent injury.

COVID-19 Impact Analysis

Cough, fever, anosmia, ageusia, difficulty breathing, and, in severe cases, pneumonia are the most common symptoms of COVID-19. People with diabetes, cardiac patients, and hypertensive patients, for instance, are more likely to present with more severe conditions. This is also seen in people with low immunity, as immunity is a powerful ally in the fight against coronavirus in the human body.

Photobiomodulation therapy (PBMT) is another method of modulating the immune system. It can stimulate immune cells to clump together at the site of the affected cells and help them survive by increasing anti-inflammatory cytokine expression and decreasing pro-inflammatory cytokine expression. In preliminary research, it was discovered that low-dose laser light accelerated the healing of excisional wounds, a process known as laser biostimulation. There was a distinct lack of agreement on the terminology for this therapy. Low-level laser therapy is the most used term (LLLT). Other light devices, such as LEDs, are currently used for this application. The effect of PBMT is due to its absorption by tissues via photoreceptors, which facilitates events such as mitochondrial respiration, calcium transport (which results in increased cell proliferation), tissue repair, and regeneration. PBMT must aid in the recovery process from the nerve, bone, respiratory tract, and other functional rehabilitation injuries, thereby favouring the patient's recovery. LLLT can be combined with the ILIB technique (Intravascular Laser Irradiation of Blood), which boosts immunity by increasing the expression of immunoglobulins (IgA, IgM, and IgG) and modulating inflammation. Hence, the increasing use of Photobiomodulation Therapy (PBMT) is expected to boost the market in the forecast period.

Segment Analysis

The red light therapy segment is expected to dominate the market growth in the forecast period

Red light therapy (RLT) is a new treatment that has shown promise in treating wrinkles, redness, acne, scars, and other aging signs. Red light therapy (RLT) is a treatment that allegedly improves the appearance of skin by reducing wrinkles, scars, redness, and acne by using low wavelength red light. It's also being touted as a treatment for other medical conditions.

For instance, red light therapy devices, such as light therapy masks, shine red and near-infrared light onto the skin, stimulating adenosine triphosphate (ATP) production within the mitochondria. Damaged cells heal faster, and new cells are produced more quickly when ATP is stimulated. Red light therapy uses red light and infrared wavelengths to penetrate the skin's layers and cells. Red light wavelengths increase collagen and elastin while also improving cell communication. It penetrates the skin superficially and aids in treating a variety of skin conditions. Near-infrared wavelengths promote healing, improve blood flow and tissue oxygenation, and increase mitochondrial function. Near-infrared wavelengths are capable of penetrating deep into the body.

Geographical Analysis

The rising incidence of psoriasis and seasonal affective disorder in this region is expected to drive the light therapy devices market. For instance, according to current research, more than 8 million people in the United States have psoriasis. According to the World Psoriasis Day consortium, 125 million people worldwide, 2 to 3% of the total population, have psoriasis. Psoriasis affects approximately 2.2 percent of the population (7.5 million people) in the United States, making it the most common autoimmune disease.

Moreover, the seasonal affective disorder affects about 5% of adults in the United States. It usually begins in adolescence. Women account for approximately 75% of those who suffer from the seasonal affective disorder. A milder form of the winter blues may affect 10% to 20% of people in the United States. Phototherapy using a special lamp, bright light therapy can treat SAD.

Hence, with the growing incidence of psoriasis and seasonal affective disorder, the demand for light therapy or phototherapy is expected to increase in the forecast period.

Competitive Landscape

The global light therapy device market is moderately competitive with increasing acquisitions, mergers and launches. Some key players in the market are Northern Light Technologies, Verilux, Inc, Koninklijke Philips N.V., Beurer, AuraDayLight, NatureBright, Lucimed SA, Lumie, Dr. Müller, GlobalMed Technologies.

GlobalMed Technologies

Overview: GlobalMed Technologies (GMT) was founded in 1996. It is a global medical technology company in Northern California's Bay Area. Specializing in lasers and other complex energy-based systems to treat various medical and cosmetic conditions, GlobalMed has represented and launched some of the industry's most recognisable brands, including VASER, BTL, Cool Touch, PhotoMedex, Radiancy, and Omnilux, over its 20-year history. GMT is present in over 45 countries and has direct regional managers in Europe and the Middle East.

Product Portfolio: Omnilux is the industry standard for non-thermal phototherapy skin treatment. The company manufactures Omnilux blue, Omnilux revive2, Omnilux plus.

Key Development: On July 15, 2021, GlobalMed Technologies (GMT) launched the Omnilux Contour line of home-use LED light therapy products in Australia and New Zealand. Contour products, the only line of home-use LED devices based on the gold standard Omnilux Medical professional light therapy system, are now available to consumers and skin care professionals in Australia and New Zealand via Omnilux online store.

Why Purchase the Report?
• Visualize the composition of the global light therapy device market segmentation by product type, by light type, and application highlighting the key commercial assets and players.
• Identify commercial opportunities in global light therapy device market by analyzing trends and co-development deals.
• Excel data sheet with thousands of data points of global light therapy device market- level 4/5 segmentation.
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
• Product mapping in excel for the key product of all major market players

The global light therapy device market report would provide an access to an approx. 45+market data table, 40+figures and 180 pages.

Target Audience
• Service Providers/ Buyers
• Industry Investors/Investment Bankers
• Education & Research Institutes
• Research Professionals
• Emerging Companies
• Manufacturers

Market Segmentation

Global Light Therapy Device Market- By Product Type
• Floor & Desk Lamps
• Light Box
• Light Visor
• Handheld Devices for Skin Treatment (HDST)
• Light Therapy Bulbs
• Others

Global Light Therapy Device Market- By Light Type
• Red Light
• Blue Light
• Others

Global Light Therapy Device Market- By Application
• Psoriasis
• Cancer
• Acne Vulgaris
• Sleeping Disorders
• Mood Disorders
• Other

Global Light Therapy Device Market- By Region
• North America
• Europe
• South America
• Asia Pacific
• Middle East and Africa